PIK3CD and Merkel cell skin cancer: Furthermore, we have shown that inhibition of PI3K/AKT/mTOR pathway by copanlisib (PI3K-α/δ) suppresses MCC cell proliferation and survival more potently than other PI3K inhibitors with single/dual isoform specificities.